The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Alendronic Acid Bluefish Once weekly 70 mg tablets

Bluefish Pharmaceuticals ABPA1436/004/001

Main Information

Trade NameAlendronic Acid Bluefish Once weekly 70 mg tablets
Active SubstancesSodium alendronate
Dosage FormTablet
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/004/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA04 alendronic acid


License statusAuthorised
Licence Issued24/04/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0051-101-002
Interchangeable List DocumentPDF of Interchangeable List
« Back